Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 392,507 | 663,302 | 570,721 | 451,723 | 456,811 |
| Marketable Securities | 275,163 | N/A | 1,134,989 | 1,154,071 | 949,239 |
| Receivables | 861,457 | 753,611 | 686,848 | 661,519 | 683,841 |
| Inventories | 570,390 | 506,557 | 447,373 | 392,936 | 362,940 |
| Other current assets | 423,704 | 3,405,368 | 404,406 | 395,139 | 416,088 |
| TOTAL | $2,523,221 | $5,328,838 | $3,244,337 | $3,055,388 | $2,868,919 |
| Non-Current Assets | |||||
| PPE Net | 1,787,776 | 1,736,811 | 1,742,200 | 1,676,583 | 1,622,812 |
| Investments And Advances | 640,991 | 306,839 | 2,310,712 | 2,012,678 | 1,739,773 |
| Intangibles | 5,889,602 | 2,792,229 | 2,832,843 | 2,885,972 | 2,930,876 |
| TOTAL | $8,318,369 | $4,835,879 | $6,885,755 | $6,575,233 | $6,293,461 |
| Total Assets | $10,841,590 | $10,164,720 | $10,130,120 | $9,630,621 | $9,162,380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 163,094 | 165,207 | 203,999 | 157,424 | 159,152 |
| Accrued Expenses | 1,056,229 | 885,093 | 979,945 | 866,208 | 762,353 |
| TOTAL | $1,304,074 | $1,281,662 | $1,657,389 | $1,521,093 | $1,432,865 |
| Non-Current Liabilities | |||||
| Long Term Debt | 726,388 | 711,831 | 687,396 | 658,442 | 641,568 |
| aiOther Non-Current Liabilities | 595,642 | 674,951 | 604,266 | 539,569 | 534,063 |
| TOTAL | $1,635,371 | $1,543,449 | $1,508,934 | $1,447,588 | $1,458,830 |
| Total Liabilities | $2,939,445 | $2,825,111 | $3,166,323 | $2,968,681 | $2,891,695 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 237,672 | 237,375 | 236,312 | 236,597 | 236,347 |
| Common Shares | 128 | 128 | 127 | 127 | 127 |
| Retained earnings | 5,404,213 | 4,913,543 | 4,486,794 | 4,194,551 | 3,796,154 |
| Other shareholders' equity | -54,181 | -67,020 | -52,651 | -48,801 | -48,243 |
| TOTAL | $7,902,145 | $7,339,606 | $6,963,795 | $6,661,940 | $6,270,685 |
| Total Liabilities And Equity | $10,841,590 | $10,164,717 | $10,130,118 | $9,630,621 | $9,162,380 |